Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : MRV Communications (MRVC) opinions? -- Ignore unavailable to you. Want to Upgrade?

To: Mike E. who wrote (28917)	12/18/2000 3:14:55 PM
From: delmarbill	Read Replies (2) \| Respond to of 42804

Anybody know if this Nortel issue was discussed at the shareholders meeting? Our OptiSwitch(TM) and other of our products may ultimately be determined to infringe the Nortel patent, or those of other companies. Nortel or other companies may pursue litigation with respect to their or other claims. The results of any litigation are inherently uncertain. In the event of an adverse result in any litigation with respect to intellectual property rights relevant to our products that could arise in the future, we could be required to obtain licenses to the infringement technology, to pay substantial damages under applicable law, to cease the manufacture, use and sale of infringing products or to expend significant resources to develop non-infringing technology. Licenses may not be available from third parties, including Nortel, either on commercially reasonable terms or at all. In addition, litigation frequently involves substantial expenditures and can require significant management attention, even if we ultimately prevail. Accordingly, any infringement claim or litigation against us could significantly harm our business, operating results and financial condition.

To: Mike E. who wrote (28917)	12/19/2000 9:34:33 AM
From: NDBFREE	Read Replies (1) \| Respond to of 42804

Excerpt from recently filed OA S-1/A relating to patents. I have to assume one of the pending Jolt patents is the one Dr. Medved mentioned in the IsraelInvestor interview last Spring. "Our strategy is to actively pursue and acquire patent protection in the United States and foreign jurisdictions for technology that we believe to be proprietary and that offers a potential competitive advantage for our inventions and technology. We own six issued U.S. patents, five issued foreign patents, thirteen patents pending in the United States, and two Patent Cooperation Treaty patent applications on various aspects of optical laser network and wireless network technologies. Three patents and eight patents pending acquired in connection with the AstroTerra Corporation acquisition as well as five patents and two patents pending acquired in connection with the Jolt Limited acquisition have substantial importance to our line of TereScope products. Assuming all maintenance fees are paid, the six U.S. patents will expire between 2013 and 2018. Assuming all annuities are paid, the five foreign patents will expire between 2012 and 2015. We intend to continue to acquire rights to and to file patent applications for various aspects of our technology in the United States and abroad. We also use copyright and trademark law to protect our proprietary information."